CA
TMO icon

Cetera Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Cetera Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$9.56M Buy
16,453
+6,327
+62% +$3.55M 0.08% 261
2023
Q4 		$5.37M Buy
10,126
+714
+8% +$346K 0.07% 253
2023
Q3 		$4.76M Buy
9,412
+309
+3% +$165K 0.07% 257
2023
Q2 		$4.75M Sell
9,103
-476
-5% -$257K 0.07% 248
2023
Q1 		$5.52M Buy
9,579
+262
+3% +$148K 0.09% 230
2022
Q4 		$5.13M Buy
9,317
+2,723
+41% +$1.44M 0.09% 228
2022
Q3 		$3.34M Buy
6,594
+280
+4% +$157K 0.09% 244
2022
Q2 		$3.43M Buy
6,314
+941
+18% +$518K 0.08% 264
2022
Q1 		$3.17M Sell
5,373
-35
-0.6% -$20.1K 0.06% 311
2021
Q4 		$3.61M Sell
5,408
-105
-2% -$65.6K 0.07% 270
2021
Q3 		$3.15M Buy
5,513
+151
+3% +$82.9K 0.06% 305
2021
Q2 		$2.71M Buy
5,362
+516
+11% +$243K 0.06% 299
2021
Q1 		$2.21M Buy
4,846
+334
+7% +$159K 0.06% 300
2020
Q4 		$2.1M Buy
4,512
+660
+17% +$309K 0.07% 266
2020
Q3 		$1.7M Buy
3,852
+469
+14% +$194K 0.06% 274
2020
Q2 		$1.23M Buy
3,383
+933
+38% +$313K 0.05% 315
2020
Q1 		$695K Buy
2,450
+975
+66% +$307K 0.04% 387
2019
Q4 		$478K Buy
1,475
+27
+2% +$8.19K 0.02% 580
2019
Q3 		$422K Buy
1,448
+67
+5% +$19.2K 0.02% 596
2019
Q2 		$404K Buy
1,381
+225
+19% +$62K 0.02% 619
2019
Q1 		$312K Sell
1,156
-183
-14% -$45.5K 0.02% 632
2018
Q4 		$299K Buy
1,339
+236
+21% +$55.4K 0.02% 627
2018
Q3 		$272K Sell
1,103
-3,423
-76% -$787K 0.01% 767
2018
Q2 		$934K Buy
4,526
+104
+2% +$22.1K 0.05% 339
2018
Q1 		$910K Buy
+4,422
New +$928K 0.05% 329
2017
Q2 		– Sell
-1,634
Closed -$254K – 865
2017
Q1 		$254K Buy
+1,634
New +$250K 0.02% 630

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cetera Advisors's TMO Position: Q1 2024 in Review

Cetera Advisors increased its Thermo Fisher Scientific (TMO) stake by 62% in Q1 2024, buying an estimated $3.55M and bringing the position to 16,453 shares worth $9.56M. The position accounts for 0.08% of the portfolio, ranked #261.

Cetera Advisors first reported a position in TMO in Q1 2017 and has held it in 26 quarters since. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Cetera Advisors held 16,453 shares of Thermo Fisher Scientific worth $9.56M as of Q1 2024.
  • Cetera Advisors bought 6,327 Thermo Fisher Scientific shares in Q1 2024, an estimated $3.55M.
  • Thermo Fisher Scientific made up 0.08% of Cetera Advisors's portfolio in Q1 2024, its #261 holding.
  • Cetera Advisors first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 26 quarters since.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.